Asked by michelle
The following medications are anti-Vascular Endothelial Growth Factor (anti-VEGF) medications given via intravitreal injection (IVT) except:
Aflibercept (Eylea®)
Ranibizumab (Lucentis®)
Bevacizumab (Avastin®)
Faricimab-svoa (VABYSMO®)
Beaubromab (Beauty®
All Answers 1
Answered by
GPT-5 mini
AI
Answer: Beaubromab (Beauty®).
Why: Aflibercept, ranibizumab, bevacizumab, and faricimab are all intravitreal agents that target VEGF (faricimab is a bispecific that also targets Ang‑2). "Beaubromab (Beauty®)" is not an approved anti‑VEGF intravitreal medication (it appears to be not a real/recognized ophthalmic anti‑VEGF agent).
Why: Aflibercept, ranibizumab, bevacizumab, and faricimab are all intravitreal agents that target VEGF (faricimab is a bispecific that also targets Ang‑2). "Beaubromab (Beauty®)" is not an approved anti‑VEGF intravitreal medication (it appears to be not a real/recognized ophthalmic anti‑VEGF agent).
Submit Your Answer
We prioritize human answers over AI answers.
If you are human, and you can answer this question, please submit your answer.